UBS Issues Rare Aggressive Buy Rating for NextVision Stock

Global financial giant UBS has issued an unusually aggressive buy recommendation for the Israeli company NextVision, which is traded solely on the Tel Aviv Stock Exchange. The recommendation has surprised market observers, particularly given the recent weak sentiment surrounding the defense sector.

UBS analysts have set a base-case target price of NIS 43 for NextVision shares, which are currently trading at roughly half that price, implying a potential doubling. In an optimistic scenario, they project a target price of NIS 68.

The Swiss bank's optimism stems from projections that NextVision will achieve $407 million in revenue by 2026, significantly exceeding the company's own recently revised upward forecast of $355 million for the year. UBS views the company's management forecast as conservative and believes NextVision will substantially surpass it.

Furthermore, UBS is optimistic about NextVision's efforts to expand production capacity, a common bottleneck for defense companies struggling to convert order backlogs into sales. The bank anticipates NextVision can increase its monthly camera production from 1,500 units to 5,000, which is expected to boost revenue and profits.

The stock reacted positively to the recommendation, rising 3% despite a generally weak local market. However, the article suggests that the initial hype may fade, and the stock could revert to being influenced by broader defense sector sentiment. The author, manager of the "Bereishit" hedge fund, notes NextVision's impressive growth rate and reasonable P/E ratio compared to other high-growth companies globally, calling it one of the more interesting local defense stocks.